Category Archive

CHMP Issues Positive Opinion To Expand Jardiance®, Synjardy® And Glyxambi® Labels To Include Positive Effects On Cardiovascular And Renal Outcomes

Kurt HarringtonJuly 2, 2018Industry News, RegulatoryLeave a Comment

Share This:

INGELHEIM, Germany & INDIANAPOLIS–(BUSINESS WIRE)–Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) announced today that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to update … Read More

GlaxoSmithKline aims to make 1B doses of vaccine booster for multiple COVID-19 partners
Source: Fierce Pharma Published on 2020-05-28 By Angus Liu
AstraZeneca locks up COVID-19 vaccine supply with Oxford BioMedica production deal
Source: Fierce Pharma Published on 2020-05-28 By Kyle Blankenship
Thermo Fisher continues global expansion push with CSL Behring biologics plant lease
Source: Fierce Pharma Published on 2020-05-27 By Kyle Blankenship
Want COVID-19 herd immunity? Get 40% of population vaccinated, says ex-FDA chief Gottlieb
Source: Fierce Pharma Published on 2020-05-27 By Angus Liu
What's needed to prove a COVID-19 vaccine works—and are top players across 3 continents there yet?
Source: Fierce Pharma Published on 2020-05-27 By Angus Liu
The Truth About Telemedicine
Source: Pharma Exec Technology Published on 2020-05-25 By Pharmaceutical Executive
FDA Leadership Shifts to Advance COVID-19 Treatments
Source: Pharma Exec Regulatory Published on 2020-05-25 By Pharmaceutical Executive
Make Content Work Harder from Start to Finish
Source: Pharma Exec Technology Published on 2020-05-24 By Pharmaceutical Executive
COVID-19: Meeting the Needs of Patients with Chronic Conditions
Source: Pharma Exec Technology Published on 2020-05-24 By Pharmaceutical Executive
Finding the Translators: Helping Connect the Science to the Patient
Source: Pharma Exec Technology Published on 2020-05-24 By Pharmaceutical Executive
How to Ride the Data Wave When Launching a New Drug
Source: Pharma Exec Technology Published on 2020-05-20 By Pharmaceutical Executive
Drive for COVID-19 Therapies Raises Patent and Pricing Issues
Source: Pharma Exec Regulatory Published on 2020-05-19 By Pharmaceutical Executive
Key Regulatory Deadlines Loom for Drug Dispensers and Wholesalers
Source: Pharma Exec Regulatory Published on 2020-05-18 By Pharmaceutical Executive
FDA's Emergency Use Process Under Scrutiny
Source: Pharma Exec Regulatory Published on 2020-05-11 By Pharmaceutical Executive
Drug Development in Wartime: Driving Tomorrow's R&D Decisions with Today's COVID-19 Data Can
Source: Pharma Exec R&D News Published on 2020-05-10 By Pharmaceutical Executive